AAPL   383.32 (+0.15%)
MSFT   213.20 (-0.52%)
FB   244.87 (+0.15%)
GOOGL   1,532.27 (+0.90%)
AMZN   3,200.87 (+0.57%)
NVDA   418.92 (-0.34%)
BABA   261.40 (-0.07%)
TSLA   1,532.47 (+9.91%)
AMD   55.90 (-2.38%)
T   30.10 (+1.90%)
ACB   11.92 (+1.27%)
F   6.07 (+3.76%)
GILD   76.31 (+2.14%)
DIS   119.19 (+2.03%)
NFLX   548.12 (+7.95%)
BA   177.87 (+2.65%)
AAPL   383.32 (+0.15%)
MSFT   213.20 (-0.52%)
FB   244.87 (+0.15%)
GOOGL   1,532.27 (+0.90%)
AMZN   3,200.87 (+0.57%)
NVDA   418.92 (-0.34%)
BABA   261.40 (-0.07%)
TSLA   1,532.47 (+9.91%)
AMD   55.90 (-2.38%)
T   30.10 (+1.90%)
ACB   11.92 (+1.27%)
F   6.07 (+3.76%)
GILD   76.31 (+2.14%)
DIS   119.19 (+2.03%)
NFLX   548.12 (+7.95%)
BA   177.87 (+2.65%)
AAPL   383.32 (+0.15%)
MSFT   213.20 (-0.52%)
FB   244.87 (+0.15%)
GOOGL   1,532.27 (+0.90%)
AMZN   3,200.87 (+0.57%)
NVDA   418.92 (-0.34%)
BABA   261.40 (-0.07%)
TSLA   1,532.47 (+9.91%)
AMD   55.90 (-2.38%)
T   30.10 (+1.90%)
ACB   11.92 (+1.27%)
F   6.07 (+3.76%)
GILD   76.31 (+2.14%)
DIS   119.19 (+2.03%)
NFLX   548.12 (+7.95%)
BA   177.87 (+2.65%)
AAPL   383.32 (+0.15%)
MSFT   213.20 (-0.52%)
FB   244.87 (+0.15%)
GOOGL   1,532.27 (+0.90%)
AMZN   3,200.87 (+0.57%)
NVDA   418.92 (-0.34%)
BABA   261.40 (-0.07%)
TSLA   1,532.47 (+9.91%)
AMD   55.90 (-2.38%)
T   30.10 (+1.90%)
ACB   11.92 (+1.27%)
F   6.07 (+3.76%)
GILD   76.31 (+2.14%)
DIS   119.19 (+2.03%)
NFLX   548.12 (+7.95%)
BA   177.87 (+2.65%)
Log in

NASDAQ:NKTRNektar Therapeutics SEC Filings & 10K Form

$24.10
-0.33 (-1.35 %)
(As of 07/10/2020 03:44 PM ET)
Add
Compare
Today's Range
$23.89
Now: $24.10
$24.50
50-Day Range
$20.26
MA: $22.43
$24.78
52-Week Range
$13.63
Now: $24.10
$35.03
Volume23,919 shs
Average Volume1.05 million shs
Market Capitalization$4.29 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.01

SEC Filings

Nektar Therapeutics (NASDAQ:NKTR) SEC Filings

DateFilerForm TypeView
05/20/2020
5:33 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:32 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:31 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:30 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:29 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
8:26 PM
Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2020
5:03 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
6:53 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2020
7:06 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
5:04 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
8:40 AM
FMR LLC (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
02/27/2020
8:29 PM
Nektar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2020
5:39 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
5:39 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
5:38 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
5:37 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:00 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
1:49 PM
Nektar Therapeutics (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/12/2020
7:02 AM
Nektar Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2020
6:31 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
2:56 PM
Nektar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/15/2020
6:00 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:00 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
6:01 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
5:31 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
8:12 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
8:39 PM
Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
8:37 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
8:36 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
8:35 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
8:34 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
8:32 PM
Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/06/2019
4:25 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
6:05 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:04 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2019
6:07 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
6:06 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
6:05 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
6:04 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2019
5:09 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:33 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
4:02 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
6:00 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
5:59 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
12:23 PM
Invesco Ltd. (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
10/02/2019
6:51 PM
Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
6:30 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
6:30 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
6:45 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2019
6:16 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
6:15 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
7:15 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
5:10 PM
EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
5:09 PM
Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
5:09 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
5:09 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
5:09 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
5:09 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
5:07 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:07 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
4:09 PM
Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
8:50 PM
Nektar Therapeutics (Filer)
Form 8-K/A
08/27/2019
4:20 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:21 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:09 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:08 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:07 PM
Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:07 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:06 PM
Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
7:13 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
9:20 AM
FMR LLC (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
08/08/2019
7:26 PM
Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:48 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
7:02 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
7:00 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
5:31 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
4:34 PM
Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
4:50 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:29 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
10:15 AM
Invesco Ltd. (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G
05/23/2019
6:19 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:22 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:22 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:21 PM
Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:20 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:19 PM
Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
7:18 PM
Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:15 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:32 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:39 PM
Nektar Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:33 PM
Nektar Therapeutics (Filer)
Form DEF 14A
03/12/2019
5:18 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:05 AM
Nektar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2019
7:17 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:16 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:15 PM
Nektar Therapeutics (Issuer)
Nicholson John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:14 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:13 PM
Hora Maninder (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:13 PM
Doberstein Stephen K (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
11:00 AM
FMR LLC (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.